The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
After promoting its oncology officer Chris Boshoff to chief scientific officer last fall, Pfizer has found his successor.
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback